The webinar “Molecular Biomarkers of Neurodegeneration” stands out for the high participation of attendees
On Friday, May 28th, we celebrated the second webinar of the cycle of free seminars Global Research Summit 2021 was held, an event organized by Ace Alzheimer Center Barcelona, with the sponsorship of Grifols, and the support of Kern Pharma and UIC, which aims to share knowledge among the scientific community dedicated to the research of dementias and other neurodegenerative diseases.
More than 165 attendees of 18 different nationalities gathered to hear the latest news on molecular biomarkers in neurodegenerative diseases. A 6% of the attendees connected from Germany, 7% from Netherlands, 8% from USA and 60% from Spain. They also joined from countries such as Switzerland, United Kingdom, Sweden, Peru, Argentina, Canada, Italy or France, among others.
The webinar stood out for the participatory attitude of attendees, since the scheduled time for the Q&A session was delayed a few minutes to deal with all the comments and questions that were being formulated through live chat. Thus, the audience could enjoy a debate between the three experts, one of the largest in the field of dementia in terms of biomarkers. The question focused on different biomarkers to differentiate between dementia typology and on the future of emerging biomarkers in the detection of Alzheimer’s disease.
With more than 65% of permanence during the 2 hours of the event, in addition to the great participation in this second webinar, the session has been valued very positively (4.7 out of 5) thanks to the high level of the speakers, the great interest of the subject matter and the format of the event.
Molecular biomarkers in neurodegenerative diseases
This second session of the Global Research Summit was focused on explaining the latest advances in molecular neuroimaging. Thus, Henrik Zetterberg, Professor and Chief Physician at Institute of Neuroscience and Physiology (University of Gothenburg), focused on updating cerebrospinal fluid-based biomarkers for the diagnosis and prognosis of Alzheimer's disease. For his part, Michelle Mielke, Professor of Epidemiology and Neurology at Mayo Clinic, did the same but updating blood biomarkers.
Thanks to the dynamic format of the webinar, viewers were able to interact with the speakers in a 1-hour question and answer session moderated by Charlotte Teunissen, Professor in Neurochemistry at VUmc.
Registration open for the third session
On June 25th, 2021 we will celebrate the webinar “Blood Circulating factors contributing to dementia pathophysiology”, from 4:30 p.m. at 6:30 p.m., with presentations by Tony Wyss-Coray and Berislav Zlokovic, the participation of Chris R Butler in the Q&A session and Mercè Boada as a host of the day.